Cart
sales@molnova.com
Dovitinib Dilactic Acid
CAS No. 852433-84-2
Dovitinib Dilactic Acid( Dovitinib Dilactic acid; TKI258 Dilactic acid; CHIR-258, TKI258 )
Catalog No. M17618 CAS No. 852433-84-2
Dovitinib Dilactic acid (TKI258 Dilactic acid) is the Dilactic acid of Dovitinib, which is a multitargeted RTK inhibitor.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 68 | Get Quote |
|
| 10MG | 103 | Get Quote |
|
| 25MG | 211 | Get Quote |
|
| 50MG | 365 | Get Quote |
|
| 100MG | 583 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDovitinib Dilactic Acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionDovitinib Dilactic acid (TKI258 Dilactic acid) is the Dilactic acid of Dovitinib, which is a multitargeted RTK inhibitor.
-
DescriptionDovitinib Dilactic acid (TKI258 Dilactic acid) is the Dilactic acid of Dovitinib, which is a multitargeted RTK inhibitor, mostly for class III (FLT3/c-Kit) with IC50 of 1 nM/2 nM, also potent to class IV (FGFR1/3) and class V (VEGFR1-4) RTKs with IC50 of 8-13 nM, less potent to InsR, EGFR, c-Met, EphA2, Tie2, IGFR1 and HER2. Phase 4.
-
SynonymsDovitinib Dilactic acid; TKI258 Dilactic acid; CHIR-258, TKI258
-
PathwayMetabolic Enzyme/Protease
-
TargetDehydrogenase
-
Recptorc-Kit; FGFR1; FGFR3; FLT3; VEGFR3/FLT4
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number852433-84-2
-
Formula Weight572.59
-
Molecular FormulaC21H21FN6O·2C3H6O3
-
Purity98%
-
Solubility——
-
SMILESCC(C(=O)O)O.CC(C(=O)O)O.CN1CCN(CC1)C2=CC3=C(C=C2)N/C(=C/4\C(=C5C(=NC4=O)C=CC=C5F)N)/N3
-
Chemical Name2-Hydroxypropanoic acid compd. with 4-amino-5-fluoro-3-[6-(4-methyl-1- piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Trudel S, et al. Blood. 2005, 105(7), 2941-2948.
molnova catalog
related products
-
DHODH-IN-16
DHODH-IN-16 is an effective inhibitor of dihydroorotate dehydrogenase (DHODH, IC50 = 0.396 nM for human).
-
IDH889
IDH889 is a brain penetrant, an allosteric and mutant specific IDH1 inhibitor. IDH889 has effective selectivity for IDH1 R132* mutations (IC50s: 0.02 μM, 0.072 μM, and 1.38 μM for IDH1R132H, IDH1R132C, and IDH1wt).
-
DHODH-IN-1
DHODH-IN-1 is a potent dihydroorotate dehydrogenase (DHODH) inhibitor with IC50 of 25 nM.
